Intellectual Property

Patents

LumiraDx products may be covered by one or more of the following patents and patent applications:

LumiraDx Platform (Instrument and Test Strip)

JP6016168B, US20130309778, CN103097029, IN1657/DELNP/2013, PCT/GB2017/051946, ARP170101903, TW106123057

LumiraDx Diagnostic Assays

EP2613881, US9919313, JP6016168B, US9341620 CN103348245m EP2673643, JP5922153, US20130309778, CN103097029, IN1657/DELNP/2013, PCT/GB2017/051946, ARP170101903, TW106123057, CN103097029, IN1657/DELNP/2013, PCT/GB2017/051946, ARP170101903, TW106123057, US20160320374A1, IN5321/DELNP/2013, GB1815278.5

LumiraDx Smart Connectivity:

LumiraDx Connect Hub

US9848386, US8606338, US8150424, US7937121, US7466979, US7187924

LumiraDx Engage

US9848386, US8606338, US8150424, US7937121, US7466979, US7187924

BetterHealthExperiencesOutcomes

Supporting healthier lives, for individuals, communities and wider society.

Enabling responsive, personal relationships between patients and care teams.

Controlling and reducing costs to help ease pressure on healthcare budgets.

Be Informed

SIGN UP FOR NEWS